This single-center study analyzed demographic, clinical, laboratory, and radiological characteristics of patients with COVID-19 admitted to Sina Hospital, Tehran, to retrospectively develop a risk score model for predicting the need for mechanical ventilation during hospitalization.
In this retrospective cohort study, 10.9% of patients required mechanical ventilation during hospitalization, while 89.1% did not. We found that patients requiring mechanical ventilation were of advanced age, had more comorbidities (including diabetes mellitus, hypertension, lung diseases, cardiovascular diseases, cerebrovascular accident, and malignancies), and more clinical and laboratory abnormalities.
In the midst of the COVID-19 pandemic, medical resources, including mechanical ventilators, face a significant shortage. According to the challenge of resource scarcity, it is crucial to have a model upon which decisions about resource allocation can be made. Developing a hospital-based risk score can provide clinicians with a valuable tool to stratify the risk of requiring mechanical ventilation during hospitalization.
Using six variables that are either available at hospital admission or can be obtained within the first hours of admission, we developed a clinical risk score to estimate the patient's risk of requiring mechanical ventilation during hospitalization. Age, history of diabetes mellitus, respiratory rate, oxygen saturation, hs-CRP, and bicarbonate level were included in the risk score.
Our findings were compatible with the previous studies, which have shown that advanced age and comorbidities can put the patients at higher risk for developing severe illness and poor prognosis. (
2,
17-
19) Among comorbidities, diabetes mellitus happened to have the most powerful correlation with the need for mechanical ventilation in our study, which was consistent with previous studies. (
20-
23)
According to the statistical analysis of the data on admission, we found that fasting blood glucose and Hb.A1c were not significantly different in mechanical ventilation and non-mechanical ventilation groups. Based on these findings, we hypothesize that the diabetes mellitus itself, rather than whether the blood glucose is controlled, can affect the course of the disease. Further studies are warranted to test this hypothesis.
In line with previous studies, we found higher CRP and respiratory rate, and lower oxygen saturation are associated with poor clinical outcomes regarding the need for mechanical ventilation. In fact, CRP is an acute-phase reactant and a marker of inflammation that has been associated with disease progression in MERS, H1N1 influenza, and recently COVID-19. (
18,
24-
30).
To the best of our knowledge, the relationship of bicarbonate and disease outcome regarding mechanical ventilation in patients with COVID-19 has not been thoroughly studied based on the review of recent literature. In our study, patients who required mechanical ventilation had significantly lower bicarbonate levels on admission. Given that the pH on admission was not significantly different in mechanical ventilation and non-mechanical ventilation groups, we think that the precise amount of serum bicarbonate can be valuable in clinical settings.
Using the risk score, the clinicians can easily categorize patients into low-, moderate-, and high-risk groups. Considering that the risk score is not the only tool in decision making, it can be used to expedite and optimize decisions in the management of patients with COVID-19.
5.1. Conclusions
This study identified the clinical factors that predict the need for mechanical ventilation in adult patients with COVID-19. Based on the findings, as mentioned earlier, we developed a risk score to stratify the risk and predict the need for mechanical ventilation in hospitalized patients with COVID-19. This model, including age, history of diabetes mellitus, respiratory rate, oxygen saturation, hs-CRP, and bicarbonate, can provide the clinicians with an evidence-based tool that can facilitate and support their decision-making in managing patients with COVID-19.
5.2. Limitation
There were several limitations to this study. This single-center study had a modest sample size. Since the data used for developing the risk score were solely obtained from one country, the results' generalizability may be potentially limited. A prospective study seems necessary to validate and confirm the reliability of the risk score.